ARCHIVES

Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA.

This article is from The Cancer Letter archive.

Vol. 31 No. 39 | October 28, 2005

Download PDF Visit The Full Archive

Related Articles

FDA Oncologic Drugs Advisory Committee Okays THC For Group C List

July 4, 1980

New CCSP And CCRU Awards Applications Under Review

January 17, 1986

FDA Authority To Regulate Off-Label Promotion Challenged In Federal Court.

January 15, 2010

In Brief: Obey Was Right- Tests On 70 Chemical Would Have Been Aborted Under NCI Budget

July 20, 1979

ASA Honors Bernard Fisher With Surgeons’ Highest Award.

April 21, 2000

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

October 31, 2003